Nothing Special   »   [go: up one dir, main page]

Covert et al., 1961 - Google Patents

Fluorescent treponemal antibody test using the Reiter treponeme.

Covert et al., 1961

Document ID
14168030116230117197
Author
Covert S
Kent J
Stevens R
Publication year
Publication venue
Proceedings of the Society for Experimental Biology and Medicine

External Links

Snippet

Fluorescent Treponemal Antibody Test Using the Reiter Treponeme. Page 1 KEITEK FLUORESCENT TREPONEMAL ANTIBODY TEST 729 people can complete this graft technic in 15 to 25 rats in one hour. The adherence of the skin, hair and outer dessicated layers of the skin …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Meuwissen et al. Parasitologic and serologic observations of infection with Pneumocystis in humans
de Man et al. Bacterial attachment and inflammation in the urinary tract
Wilson Studies on the opsonic activity of human secretory IgA using an in vitro phagocytosis system
Backhouse et al. Failure of penicillin treatment of yaws on Karkar Island, Papua New Guinea.
Gladstone et al. The Assay of Anti-staphylococcal Leucocidal Components (F. and S) in Human Serum
Moody et al. Fluorescent-antibody identification of group A streptococci from throat swabs
Lewis et al. Enzyme-linked immunosorbent assay for chlamydial antibodies
FI901791A0 (en) ASSESSMENT OF LYMPHOCYCLE REACTIVITY IN FOERHAOLLANDE TILL SPECIFIKA ANTIGENER I BLODET.
Covert et al. Fluorescent treponemal antibody test using the Reiter treponeme.
Lack et al. Serological tests for staphylococcal infection
Affronti et al. Serodiagnostic test for tuberculosis
Park et al. The significance of specific IgG and IgG4 antibodies to a reactive dye in exposed workers
Somers et al. Blood group antibodies in old age
RICHMOND et al. Antibodies to Chlamydia trachomatis in Cervicovaginal Secretions: Relation to Serum Antibodies and Current Chlamydia1 Infection
Yunis et al. Cell Antigens and Cell Specialization: I. A Study of Blood Group Antigens on Normoblasts
Edwards et al. Comparison of the indirect fluorescent antibody test with agglutination, complement-fixation, and Coombs tests for Brucella antibody
Szyfres et al. A modified slide latex screening test for hydatid disease
Patterson et al. In vitro production of IgE by lymphocytes from a patient with hyperimmunoglobulinaemia E, eosinophilia and increased lymphocytes carrying surface IgE.
Thalhimer et al. A slide test modification of the hemagglutination test for antibodies against tubercle bacilli
Eisner et al. Quinidine-induced agranulocytosis
Oates et al. Results of Cultural and Serological Tests for Pleuropneumonia-like Organisms in Reiter's Disease
Kent et al. Evaluation of fluorescent treponemal antibody (RFTA and FTA II) and other tests (RPCF and TPI) for syphilis
Idoko et al. Neutrophil cell function and migration inhibition studies in Nigerian patients with tropical pyomyositis
Moss et al. The action of “low potency” homœopathic remedies on the movement of guinea-pig macrophages and human leucocytes
HARDING et al. The epidemiology of primary atypical pneumonia